Literature DB >> 24981435

Oncolytic viruses: immune or cytolytic therapy?

John Bell1.   

Abstract

Mesh：

Year:  2014        PMID： 24981435      PMCID： PMC4089006          DOI： 10.1038/mt.2014.94

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model.

Authors:  Huan Zhang; Weimin Xie; Yuning Zhang; Xiwen Dong; Chao Liu; Jing Yi; Shun Zhang; Chunkai Wen; Li Zheng; Hua Wang
Journal:  Cancer Gene Ther       Date:  2021-09-24       Impact factor: 5.854

2.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

3.  Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain.

Authors:  Biao Wang; Xu Yan; Qingguo Guo; Yan Li; Haiyan Zhang; Ji Sheng Xie; Xin Meng
Journal:  Oncotarget       Date:  2015-06-30

4.  Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade.

Authors:  Yang Liu; Jing Cai; Wenfeng Liu; Yuan Lin; Li Guo; Xincheng Liu; Zhen Qin; Cuiying Xu; Yanming Zhang; Xingwen Su; Kai Deng; Guangmei Yan; Jiankai Liang
Journal:  Cell Death Dis       Date:  2020-12-12       Impact factor: 8.469

Review 5.  Going viral: a review of replication-selective oncolytic adenoviruses.

Authors:  Christopher Larson; Bryan Oronsky; Jan Scicinski; Gary R Fanger; Meaghan Stirn; Arnold Oronsky; Tony R Reid
Journal:  Oncotarget       Date:  2015-08-21

Review 6.  On the potential of oncolytic virotherapy for the treatment of canine cancers.

Authors:  Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2015-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.